These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7732568)
1. Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome. Meisels IS; Strom TB; Roy-Chaudhury P; Abrams J; Shapiro ME Transplantation; 1995 Apr; 59(8):1214-5. PubMed ID: 7732568 [No Abstract] [Full Text] [Related]
2. Cytokine-release syndrome: differences between high and low doses of OKT3. Norman DJ; Kimball JA; Barry JM Transplant Proc; 1993 Apr; 25(2 Suppl 1):35-8. PubMed ID: 8465420 [No Abstract] [Full Text] [Related]
3. Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3). Noël C; Hazzan M; Coppin MC; Pruvot FR; Bridoux F; Lelièvre G Transplant Proc; 1995 Aug; 27(4):2438-9. PubMed ID: 7652870 [No Abstract] [Full Text] [Related]
4. Monitoring of donor sensitization in kidney transplant recipients by flow cytometric crossmatch. Cinti P; Bachetoni A; Baiano V; Pretagostini R; Poli L; Berloco P; Renna Molajoni E; Cortesini R Transplant Proc; 1993 Dec; 25(6):3265-6. PubMed ID: 8266536 [No Abstract] [Full Text] [Related]
5. Posttransplant renal allograft dysfunction as a prognostic factor in triple therapy-treated patients. Pallardó LM; García J; Sánchez J; Górriz JL; Orero E; Calabuig F Transplant Proc; 1992 Feb; 24(1):113-4. PubMed ID: 1539199 [No Abstract] [Full Text] [Related]
6. Late acute rejection in renal transplant recipients: response to steroid treatment. Prieto C; Pulido F; Rodríguez-Paternina E; Algranati C; Bello I; Farias J; G-Millet V Transplant Proc; 1992 Feb; 24(1):35-6. PubMed ID: 1539312 [No Abstract] [Full Text] [Related]
7. Five-year experience with a triple drug protocol in renal transplantation. Pallardó LM; Sánchez J; García J; Puig N; Sánchez P; Górriz JL; Cruz JM Transplant Proc; 1992 Feb; 24(1):56-7. PubMed ID: 1539342 [No Abstract] [Full Text] [Related]
8. Triple drug maintenance therapy in renal transplantation. Pallardó LM; Sánchez J; Hernandez M; Górriz JL; Sánchez P; Beneyto I; Rochera A Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343 [No Abstract] [Full Text] [Related]
10. Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients. Buturović-Ponikvar J; Kandus A; Malovrh M; Ponikvar R; Kveder R Transplant Proc; 1992 Oct; 24(5):1921-3. PubMed ID: 1329287 [No Abstract] [Full Text] [Related]
11. Pediatric renal transplantation in a single center from Brazil. Abbud-Filho M; Ramalho H; Barberato JB; Silva ML; Yamazaki W; Salgueiro MC; Zerati-Fo M; D'Avila CL; Bezas AG Transplant Proc; 1995 Apr; 27(2):1834. PubMed ID: 7725526 [No Abstract] [Full Text] [Related]
12. Correlation between Banff classification, acute renal rejection scores, and reversal of rejection. Gaber LW; Moore LW; Alloway RR; Flax S; Gaber AO Transplant Proc; 1995 Feb; 27(1):1019. PubMed ID: 7878784 [No Abstract] [Full Text] [Related]
13. The influence of cold ischemia and donor age on renal allograft outcome in the cyclosporine era. Cacciarelli TV; Sumrani N; DiBenedetto A; Hong JH; Sommer BG Transplant Proc; 1992 Oct; 24(5):2044-5. PubMed ID: 1412966 [No Abstract] [Full Text] [Related]
14. Living-related and living-unrelated kidney transplantation using low-dose triple immunosuppression. Francis DM; Walker RG; Millar RJ; Becker G Transplant Proc; 1992 Oct; 24(5):1887-8. PubMed ID: 1412899 [No Abstract] [Full Text] [Related]
15. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children. Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630 [No Abstract] [Full Text] [Related]
16. Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation? Mozes MF; Venkat KK; Kupin W; Dumler F; Gracida C; Uniewski M; Anaise D; Tang DH Transplant Proc; 1993 Feb; 25(1 Pt 1):575-6. PubMed ID: 8438420 [No Abstract] [Full Text] [Related]
17. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival. Howard RJ; Pfaff WW; Brunson ME; Ramos EL; Peterson JC; Croker BP; Scornik JC; Parris CJ; Fennell RS Transplant Proc; 1993 Feb; 25(1 Pt 2):884. PubMed ID: 8442256 [No Abstract] [Full Text] [Related]
18. Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection. Carvalho MF; Adoni T; Saggioro FP; Soares V Transplant Proc; 1998 Sep; 30(6):2876-7. PubMed ID: 9745607 [No Abstract] [Full Text] [Related]
19. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation. Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548 [No Abstract] [Full Text] [Related]
20. Clinical results of quadruple drug immunosuppression in liver transplantation. Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217 [No Abstract] [Full Text] [Related] [Next] [New Search]